Shareholders to Vote on Massive Dilution: Reverse Split Authority, 585% Dilutive Warrants, and $30M in New Offerings
XXII sits 20% above its 52-week low of $5.414.
Summary
22nd Century Group is seeking shareholder approval for multiple highly dilutive capital raises and discretionary reverse stock split authority, signaling severe financial distress and a desperate attempt to maintain Nasdaq listing and secure funding.
Key Events · Financing and Capital Events · XXII
-
Shareholder Vote on Reverse Stock Split Authority
The Board seeks discretionary authority for another reverse stock split (1-for-2 to 1-for-200) to maintain Nasdaq listing, without reducing authorized shares. This follows six previous reverse splits since July 2023, including one on the same day as this filing.
-
Approval for Highly Dilutive Inducement Warrants
Shareholders will vote on issuing 3,019,586 inducement warrants at an exercise price of $6.32. This represents a potential dilution of approximately 584.8% based on 516,328 outstanding shares as of June 12, 2026.
-
Approval for Potential Future $20M Preferred Stock Offering
The company seeks approval for a potential future offering of up to $20 million in new convertible preferred stock and warrants, convertible at potentially deep discounts. This is a substantial capital raise relative to the company's market cap.
-
Approval for Potential Future $10M Common Stock Offering
The company seeks approval for a potential future offering of up to $10 million in common stock and accompanying warrants, also at potentially dilutive terms.
Analysis · XXII · Manufacturing
22nd Century Group is seeking shareholder approval for a series of highly dilutive measures to address its severe financial distress and maintain its Nasdaq listing. The request for authority to implement another reverse stock split, following six previous ones, highlights persistent compliance issues. The proposed issuance of 3,019,586 inducement warrants, which could dilute existing shareholders by nearly 600%, is particularly alarming given the exercise price is close to the current market price. Additionally, the company is seeking approval for two future offerings totaling up to $30 million in new equity and warrants, which is more than its current market capitalization. These actions collectively indicate a desperate need for capital that will come at a significant cost to current shareholders, further exacerbating the "going concern" doubts previously disclosed.
At the time of this filing, XXII was trading at $6.52 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $5.41 to $4,899.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.